BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 10387974)

  • 1. Thrombopoietin: Biology and Clinical Applications.
    Kuter DJ
    Oncologist; 1996; 1(1 & 2):98-106. PubMed ID: 10387974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thrombopoietin: biology and clinical potentials.
    Miyazaki H; Kato T
    Int J Hematol; 1999 Dec; 70(4):216-25. PubMed ID: 10643146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombopoietin: biology, clinical applications, role in the donor setting.
    Kuter DJ
    J Clin Apher; 1996; 11(3):149-59. PubMed ID: 8915820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of a novel, small non-peptidyl molecule butyzamide on human thrombopoietin receptor and megakaryopoiesis.
    Nogami W; Yoshida H; Koizumi K; Yamada H; Abe K; Arimura A; Yamane N; Takahashi K; Yamane A; Oda A; Tanaka Y; Takemoto H; Ohnishi Y; Ikeda Y; Miyakawa Y
    Haematologica; 2008 Oct; 93(10):1495-504. PubMed ID: 18728031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical use of thrombopoietin (c-Mpl Ligand)].
    Borota R; Borota J; Belić A; Gebauer E; Stefanović N
    Med Pregl; 1998; 51(11-12):501-8. PubMed ID: 10081270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant human thrombopoietin: clinical experience and in vivo biology.
    Vadhan-Raj S
    Semin Hematol; 1998 Jul; 35(3):261-8. PubMed ID: 9685172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant human thrombopoietin (rhTPO) after autologous bone marrow transplantation: a phase I pharmacokinetic and pharmacodynamic study.
    Wolff SN; Herzig R; Lynch J; Ericson SG; Greer JP; Stein R; Goodman S; Benyunes MC; Ashby M; Jones DV; Fay J
    Bone Marrow Transplant; 2001 Feb; 27(3):261-8. PubMed ID: 11277173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombopoietin mimetic agents in the management of immune thrombocytopenic purpura.
    Newland A
    Semin Hematol; 2007 Oct; 44(4 Suppl 5):S35-45. PubMed ID: 18096471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do the preclinical effects of thrombopoietin correlate with its in vitro properties?
    Kaushansky K; Broudy VC; Sitnicka E; Lofton-Day C; Grossmann A; Sprugel K
    Stem Cells; 1996; 14 Suppl 1():108-11. PubMed ID: 11012209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical studies with megakaryocyte growth and development factor (Mpl-ligand).
    Begley CG
    Thromb Haemost; 1997 Jul; 78(1):42-6. PubMed ID: 9198125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of platelet growth factors in cancer therapy.
    Clarke K; Basser RL
    Stem Cells; 1996; 14 Suppl 1():274-80. PubMed ID: 11012231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of Mpl ligands on platelet production and function in nonhuman primates.
    Harker LA; Marzec UM; Kelly AB
    Stem Cells; 1998; 16 Suppl 2():107-19. PubMed ID: 11012183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical use of recombinant human thrombopoietin. Status and perspectives].
    Hansen PB; Hasselbalch HC
    Ugeskr Laeger; 2001 May; 163(19):2659-62. PubMed ID: 11360368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical approaches involving thrombopoietin to shorten the period of thrombocytopenia after high-dose chemotherapy.
    Tijssen MR; van der Schoot CE; Voermans C; Zwaginga JJ
    Transfus Med Rev; 2006 Oct; 20(4):283-93. PubMed ID: 17008166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombopoietin: biology and potential clinical applications.
    Prow D; Vadhan-Raj S
    Oncology (Williston Park); 1998 Nov; 12(11):1597-604, 1607-8; discussion 1611-4. PubMed ID: 9834938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physiologic role of TPO in thrombopoiesis.
    Miyazaki H
    Stem Cells; 1996; 14 Suppl 1():133-8. PubMed ID: 11012213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early suppressive effects of chemotherapy on recovery of bone marrow megakaryocyte precursors: possible relationship to platelet recovery.
    Warren MK; Zujewski J; Rose WL; Szabo JM; O'Shaughnessy JA; Halverson DC; Cowan KH; Gress RE; Schwartz GN
    Stem Cells; 1996; 14 Suppl 1():31-7. PubMed ID: 11012200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A multi-center clinical trial of recombinant human thrombopoietin in the treatment of chemotherapy-induced thrombocytopenia in patients with solid tumor].
    Bai CM; Xu GX; Zhao YQ; Han SM; Shan YD
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Aug; 26(4):437-41. PubMed ID: 15379272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suspects in the tale of lupus-associated thrombocytopenia.
    Ziakas PD; Routsias JG; Giannouli S; Tasidou A; Tzioufas AG; Voulgarelis M
    Clin Exp Immunol; 2006 Jul; 145(1):71-80. PubMed ID: 16792676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies of the c-Mpl thrombopoietin receptor through gene disruption and activation.
    Alexander WS; Roberts AW; Maurer AB; Nicola NA; Dunn AR; Metcalf D
    Stem Cells; 1996; 14 Suppl 1():124-32. PubMed ID: 11012212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.